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Given the recognized role of the commensal microbiota in regulating host immunity to pathogens, it is not
surprising that microbiota are also capable of regulating autoimmune responses. The underlying mecha-
nisms of autoimmune regulation by the microbiota are just beginning to emerge. Here, we discuss possible
pressure points toward the development of autoimmune diseases that can be influenced by the microbiota.
Besides acting on the adaptive and innate arms of the immune response, themicrobiota can affect the targets
of autoimmunity directly, even during development in utero, and be involved in regulation of autoimmunity via
interactions with hormones.Introduction
Research of the past decade has helped us appreciate the
importance of the commensal microbiota in autoimmune dis-
ease development (Chervonsky, 2010). Along the way, the diffi-
culties in understanding the mechanisms by which microbes
influence autoimmune disease pathogenesis have also become
apparent. The confounding factors to understanding the under-
lying mechanisms include: (1) the enormous complexity of the
microbiota; (2) involvement of microbial communities rather
than isolated lineages in interactions with the host; (3) sensitivity
of the microbiota to various environmental insults including
dietary, chemical, and biological; (4) the multiplicity of host
microbial sensors; and (5) the difficulties in applying classical
Koch’s postulates to commensal microbes. The revival of the
gnotobiotic approach (colonization of germ-free animals with
defined microorganisms or their consortia) and its application
in the context of animal models of autoimmunity have helped
alleviate some of the constraints noted above and have led to
several important conclusions. Here, we review recent findings
that link the microbiota to the development of autoimmune dis-
ease and discuss the points where microbiota can potentially
apply pressure on the path to autoimmune development, draw-
ing specific examples from the literature where available.
Exploring Microbial Connections to Autoimmunity
Mouse models of human monogenic diseases such as immuno-
dysregulation polyendocrinopathy enteropathy X-linked syn-
drome (IPEX) and autoimmune polyendocrinopathy candidiasis
ectodermal dystrophy (APECED)—mice harboring Foxp3 and
AIRE lesions, respectively—were shown to be independent of
microbiota, whereas models of polygenic diseases such as
Type 1 diabetes (T1D), rheumatoid arthritis (RA), or multiple
sclerosis (MS) were found to be affected by the microbiota.
Importantly, some autoimmune conditions such as T1D in
predisposed non-obese diabetic (NOD) mice and BB rats
developed without the presence of microbes, whereas others
were either augmented by microbes or required their presence
for disease onset. These results imply some level of specificity
in the ability of microbial lineages to induce different diseases.548 Cell Host & Microbe 17, May 13, 2015 ª2015 Elsevier Inc.For example, mono-colonization with segmented filamentous
bacteria (SFB) augmented rheumatoid arthritis (RA) in a mouse
model (Wu et al., 2010) but had no effect in the context of T1D
(Yurkovetskiy et al., 2013). However, the variability in the ge-
nomes of bacteria commonly identified as SFB could explain
why this bacteriumwas protective in an earlier T1D study (Kriegel
et al., 2011). Despite these complications, we have learned
that microbes can be protective, neutral, or provocative for the
development of autoimmunity.
The gnotobiotic approach can potentially be used to study the
effects of the human and animal microbiota on animal pathology.
However, it is not a high-throughput method and the few
available animal models are unlikely to fully represent the diverse
human pathologies associated with Systemic Lupus Erythema-
tosus (SLE) or T1D. On the other hand, high-throughput methods
of microbiota analysis, including sequencing of 16S rRNA genes,
whole-microbial genome sequencing, and metabolomic anal-
ysis, have enabled studies with patients and matching control
human populations to assess associations between autoim-
mune disease and microbial communities. For example, studies
on three human cohorts that included T1D patients have found
links betweenmicrobiota composition and autoimmune disease.
All three studies were done in Scandinavia where the incidence
of T1D is high. However, the cohorts analyzed were relatively
small (between 8 and 36 subjects including healthy controls
[Brown et al., 2011, de Goffau et al., 2013, Kostic et al., 2015]).
For comparison, genome-wide association studies (GWASs) of
T1D patients usually involve thousands of cases and samples
allowing the identification of rather small contributions of indi-
vidual genes to disease development. Not surprisingly, the
microbial associations with T1D differed in these studies. Brown
et al. and De Goffau et al. identified a decrease in lactate- and
butyrate-producing bacteria as being associated with develop-
ment of autoimmunity, whereas Kostic et al. did not see similar
changes in patients that developed autoimmunity during the
study period. Differences in methods (sequencing bias due to
different read depths or different hypervariable regions of 16S
rRNA amplification used for analysis) and study groups (patients
with established T1D versus patients with anti-pancreatic
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differences in the results. Importantly, all studies repeatedly
found that diabetic patients had one common trend—the
alpha-diversity of their microbiota was reduced. The reduction
of microbial diversity, usually referred to as dysbiosis, is also a
feature of Inflammatory Bowel Disease (IBD) (see Review in
this issue by Wlodarska et al. 2015), suggesting the existence
of important underlying commonalities between very different
inflammatory conditions.
The microbiota is extremely sensitive to dietary changes (Wu
et al., 2011; Carmody et al., 2015) and likely also to changes in
the host’s metabolism. Given that T1D significantly affects host
metabolism, microbial community alterations observed in T1D
patients could actually be dictated by the disease itself (Kostic
et al., 2015). Indeed, recent studies have suggested that changes
in stool metabolites (caused by changes in microbiota composi-
tion) can serve as biomarkers for predicting overt diabetes (Scher
et al., 2013; Kostic et al., 2015). Finding a correlation between the
composition of microbial communities and autoimmune dis-
eases and eventual proof of their diagnostic or therapeutic value
constitute an important part of the research in this area. This re-
quires prospective and longitudinal studies with larger cohorts
of patients, such as the TEDDY study (Hagopian et al., 2006).
The discovery of specific activating and inhibitory receptors
triggered by the microbiota and engaged in autoimmunity is
another avenue toward understanding the microbiota-autoim-
munity connection. These studies can produce important infor-
mation even without a complete knowledge of the microbial
perpetrator’s identity.
Provision of Ligands for Adaptive Immunity
It has long been known that pathogenic microbes can potentially
provide ligands that elicit cross-reactivity with self-antigens
(molecular mimicry) (Oldstone, 1987; Wucherpfennig and Stro-
minger, 1995), and this has also been proposed as a possible
link between commensal microbiota and autoimmunity (Cher-
vonsky, 2009). Novel approaches involving MHC (Major Histo-
compatibiity Complex)-peptide tetramers in humans (Su et al.,
2013) and mice (Nelson et al., 2015) have provided concrete
evidence for the existence of T cell receptors (TCRs) that
cross-react to peptides that the host was not previously exposed
to. Synthetic peptides derived from microbes were able to acti-
vate cells carrying such TCRs. Although these results provide a
solid basis for further experiments that could prove that TCRpro-
miscuity leads to autoimmunity, direct proof of this occurring
in vivo remains outstanding. For homologous or even identical
peptides to elicit a T cell response, they have to become avail-
able to MHC-expressing antigen-presenting cells (APCs) and
be properly processed by proteases and by the peptide-loading
machinery. It is not impossible that the reduction of microbial di-
versity associated with inflammatory and autoimmune diseases
(Brown et al., 2011; Scher et al., 2013) creates conditions under
which microbes or their products can more efficiently cross the
epithelial barriers and be appreciated by APCs. Solid evidence
for the role of commensals in providing antigens for the activa-
tion of the host’s cross-reactive T cells is desperately needed.
In that regard, the recent finding that arthritis-promoting SFB
(Wu et al., 2010) also elicit Th17 T cell responses against them-
selves (Yang et al., 2014) is very intriguing. It remains to beseen whether molecular mimicry is involved in the modulation
of autoimmunity by these bacteria.
Influencing the Cells of the Immune System
The host immune system plays an important role in shaping
the microbiota and, reciprocally, host-associated microbes
significantly influence the development and function of innate
and adaptive immunity (reviewed by Hooper et al., 2012).
Commensal microbes are sensed by multiple innate immune
sensors. Signaling through innate immune receptors ultimately
leads to activation of adaptive immune responses. Thus, mi-
crobes are likely to challenge the activation of adaptive autoim-
munity by interfering with innate-adaptive communication
(Chervonsky, 2010). Cells of the innate immune system such
as dendritic cells, macrophages, neutrophils, and NK cells are
necessary for the development of many types of autoimmunity
and microbes can also influence the activity of these types of
cells. Macrophages isolated from germ-free mice release lower
levels of TNF-a and higher levels of IL-10 when stimulated with
bacterial lipopolysaccharide (LPS) compared to macrophages
from specific pathogen-free (SPF) mice (Souza et al., 2004).
Though total numbers of splenic dendritic cells are not much
different between germ-free and SPF animals, microbial activa-
tion of these cells leads to decreased expression of IL-15, IL-6,
TNF-a, and type I interferons. NK function is also impaired under
germ-free conditions, possibly due to the inability of monocyte-
derived cells to produce type I interferons in response to micro-
bial stimuli (Ganal et al., 2012). The proper function and activity of
bone marrow-derived neutrophils is highly influenced by expo-
sure to commensal organisms, likely in the form of circulating
microbial products such as muramyl di-peptide (MDP) (Clarke
et al., 2010). iNKT cells, which also contribute to several autoim-
mune diseases, have some defects in the germ-free environment
and require microbial ligands for their maturation (Wingender
et al., 2012; An et al., 2014).
Germ-freemice are reported to also have distinct alterations in
their adaptive immune system including decreased numbers of
T and B cells, decreased levels of IgA and IgG antibodies, and
a strong skewing toward the Th2 CD4+ T cell helper subset.
Introduction of microbes to germ-free mice restores the Th1
and Th17 compartments. Development of inducible regulatory
T cells (iTregs) in the periphery is dependent on interactions
with the microbiota and is influenced by microbially produced
short-chain fatty acids (Arpaia et al., 2013). Tregs do have a
measurable degree of control over developing autoimmunity
because their ablation in T1D-susceptible mice leads to immedi-
ate overt diabetes (Feuerer et al., 2009). The programming of
both innate (Ganal et al., 2012) and adaptive (Arpaia et al.,
2013) cells by microbial products is probably mediated through
epigenetic changes at transcription factor target sites.
Indirect Modulation of Autoimmunity
In addition to the well-appreciated direct effects of microbiota on
the immune system as discussed above, there are also indirect
ways for microbiota to affect autoimmunity.
Affecting the Target Organs
GWAS evidence suggests that organs targeted in autoimmunity
may not just be passive bystanders in the face of immune-
mediated attack (Santin and Eizirik 2013; International MultipleCell Host & Microbe 17, May 13, 2015 ª2015 Elsevier Inc. 549
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which are heavily dependent on consumed nutrients, could
serve as links between the microbiota and the host’s organs.
One can envision a role of microbial metabolites in regulating
the stress experienced by the target organ, either easing it or
exacerbating it. For example, the increased resistance of
pancreatic beta cells to stress could reduce apoptosis and the
supply of autoantigens, thus reducing the pace or magnitude
of autoreactive beta cell-specific T cell activation. The resulting
slow kinetics of activation may also provide a better chance for
Tregs to exert immune control.
Diet is undoubtedly very important in influencing themetabolic
functions of the microbiota and the host (Scott et al., 2013; Car-
mody et al., 2015). Since diet-induced shifts in the microbiota
may have a role in development of autoimmunity, it is tempting
to speculate that the beneficial impact of dietary intervention
(for example in T1D) is due to changes in the microbiota. How-
ever, a recent study in T1D-predisposed BB-rats (Patrick et al.,
2013) identified a semi-purified diet that was protective against
T1D in both SPF and germ-free conditions, indicating that the
protection against disease was independent of the microbiota.
Whether this type of dietary intervention has a direct impact on
beta cell function is unknown. Interestingly, a recent clinical trial
of a similarly designed baby formula failed to provide significant
protection from anti-pancreatic antibody development (Knip
et al., 2014). Clearly there are still many unknown factors,
including the role of the microbiota, which could influence the
outcome of such a treatment.
Developmental Influences
Unlike invertebrates such as Drosophila or hydra (Shin et al.,
2011; Rahat and Dimentman, 1982), mammalian development
does not seem to be directly and irreversibly influenced by mi-
crobiota (with the important note that developing germ-free
animals are always artificially provided with necessary nutrients).
That seems to also be true for the immune system. Although
germ-free animals have an underdeveloped mucosa-associated
lymphoid tissue and less activated local and global adaptive
immune system (Sommer and Ba¨ckhed, 2013), their immune
functions can be restored to apparently normal states by coloni-
zation with commensal microbes (Smith et al., 2007).
Nevertheless, the environment experienced both during
gestation and during early-life development may lead to pheno-
typic states different from what genetics alone would predict.
Though there is a paucity of evidence for transgenerational
imprinting on the function of the immune system, there is
mounting evidence that malnutrition and parental experiences
such as stress and obesity can contribute to metabolic disease
development in the offspring (Aiken and Ozanne, 2014; Radford
et al., 2014). Since the microbiota can contribute to metabolic
dysfunction, it may be considered an environmental factor in
transgenerational extra-genetic phenotype programming.
In the few experiments relevant to autoimmunity, exposure of
NOD mice to a special diet formulation until weaning age was
sufficient to decrease the incidence of T1D, as long as these
animals were also exposed to the same diet in utero (Kagohashi
and Otani, 2015).
Another dietary intervention during gestation, maternal expo-
sure to gluten, affected the development of T1D: the progeny
of NOD mothers fed gluten-free diet during pregnancy and550 Cell Host & Microbe 17, May 13, 2015 ª2015 Elsevier Inc.exposed to gluten-containing chow throughout their life had a
substantially decreased T1D incidence (Hansen et al., 2014).
The potential role of the microbiota in this process has not
been addressed. In a different experiment, maternal environ-
ment has also been shown to affect the development of T1D,
as embryos transplanted from NOD mice to DBA/2 females
were protected from development of the disease after birth
(Greeley et al., 2002). Thus, contributions from thematernal envi-
ronment may play a role in shaping microbiota composition and
thereby influence the risk for disease development.
Pregnancy itself imposes changes upon the intestinal micro-
biota in humans: the third trimester microbiota induced greater
adiposity and insulin resistance when transferred to germ-free
animals compared to microbiota at the first trimester (Koren
et al., 2012). The risk for development of T1D may thus be linked
to the imprinting of metabolic functions of the insulin-producing
beta cells.
Long-lasting imprinting effects may not necessarily be
affecting the target organs alone, but also the developing
immune system. In this regard, it is important to note that several
populations of immune cells have been recently found to be
long living and embryonically derived, such as tissue-resident
macrophages and B1 B cells (Gomez Perdiguero et al., 2015;
Montecino-Rodriguez and Dorshkind, 2012). These cell types
are likely to be affected by the microbiota and related metabolic
cues during development and later contribute to the overall
status of the immune system and responses to self and foreign
antigens.
Hormones and Microbes
Sexual dimorphism is an important aspect of many autoimmune
diseases and an unexpected role for the microbiota in mediating
this sexual dimorphism has been recently uncovered. Previous
experiments have suggested that male hormones are protective
in SLE or T1D and estrogens may contribute to disease progres-
sion (reviewed in Markle and Fish, 2014). Two recent studies
have connected hormonal influences and microbiota to explain
the sexual dimorphism of autoimmunity (Markle et al., 2013;
Yurkovetskiy et al., 2013). They were based on previous findings
that germ-free animals lose the sexual dimorphism of T1D, with
both females and males having a high incidence of the disease.
Both studies found that microbiota between male and female
littermates differ after puberty and that the microbiota con-
tributed to increased levels of testosterone in the blood. The
microbiota of castratedmales wasmore similar to themicrobiota
of post-pubescent females than to that of post-pubescent
males. However, overall these studies did not reveal a gender-
specific microbiota signature, as the differences in bacterial
composition between males and females did not overlap in mul-
tiple sequencing experiments. While the two studies concur that
colonization with microbes increases the levels of androgens
in the blood, they differed in their interpretation of the results.
Markle et al. found that the transfer of malemicrobiota to females
was protective and suggested a linear model wherein microbiota
induced testosterone that then affects autoimmunity. Based on
the lack of a correlation between the levels ofmicrobially induced
testosterone and the ability of particular microbes to prevent
T1D, Yurkovetskiy et al. suggested a dual signal hypothesis. In
this hypothesis, signals from both hormones and microbiota
were required to ensure male protection from T1D. Interestingly,
Figure 1. Environment, Diet, and Microbes May Influence the
Development of Autoimmunity at Various Stages of Life
Themicrobiotamay impinge on autoimmunity inmany ways. It can be a source
of peptide ligands for T cell recognition, structural components (Pathogen-
Associated Molecular Patterns [PAMPs]) recognized by innate immune
receptors, and metabolites that can serve as an energy source or regulate
cellular biosynthetic and signaling pathways. Besides direct effects on the
adaptive and innate immune systems, microbial PAMPs and metabolites can
affect the target organs (such as pancreas or neural tissue), changing the levels
of stress experienced by these organs and thus affecting the pace with which
autoimmunity is activated. Diet can affect target organs directly or through the
microbiota. These influences do not start after birth but may occur in the
mother’s womb, predisposing the progeny to disease. The microbiota also
cooperates with the endocrine system to drive sexual dimorphism, a promi-
nent feature of the major autoimmune conditions.
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tection) was achieved by mono-colonization with bacteria of
entirely unrelated genera. Bacteria as different as SFB and an
E.coli-like species both induced protection in males. This result
also suggested the existence of multiple mechanisms of micro-
bial involvement in promoting sexual dimorphism.
Whether microbes contribute to sexual dimorphism in other
autoimmunity models remains to be examined. Investigation of
the role of the microbiota in biasing autoimmunity in humans
may be more productive if it is not solely based on microbiota
surveys but on the translation of discoveries of signaling path-
ways regulated by the endocrine system and microbes in animal
models.
Concluding Remarks
We have suggested several underappreciated contact points
where the microbiota can exert its influence on inflammatory
and autoimmune diseases (see Figure 1). Additionally, several
viruses were recently found to depend on the microbiota for
their propagation. Remarkably, T1D induction in rats by Kilham
virus was sensitive to antibiotics (Hara et al., 2012). The involve-
ment of viruses and their linkage with bacterial commensals
further complicate the understanding of the microbiota’s role in
autoimmunity.
Needless to say, the overall picture has proven to be more
complex than the original linear interpretations of the microbio-ta’s effects. To add to the complexity, many effects are likely
to be species specific and direct translation from rodents to
humans and back must be made with caution. The well-estab-
lished anti-inflammatory effects of Bacteroides fragilis have
been observed in mice, but this commensal is known to cause
inflammatory responses in humans. SFB is another example
that has defined pro- and anti-autoimmune effects in mice but
does not have an obvious human counterpart. These difficulties
should not discourage future investigations, because although
microbes involved in autoimmunity could be different between
species due to genetic control, diet, and lifestyle, the principles
of microbial participation and pathway regulation are most likely
very similar.
Contemporary methods of high-throughput analysis of micro-
bial communities and their metabolomes, in combination with
classical bacterial and mammalian genetics, should be able to
identify the critical pathways and bring us closer to knowl-
edge-based therapies.
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